Feasibility of a Breath Test for Monitoring Adherence to Vaginal Administration of Antiretroviral Microbicide Gels

Abstract

Adherence to microbicide gel use is critical to optimizing effectiveness in preventing human immunodeficiency virus transmission. The authors hypothesized that ester taggants added to vaginal gels would generate exhaled alcohol and ketone metabolites and provide a "breath test" for vaginal gel use. This 2-arm (vaginal and dermal), randomized, participant-blinded, pilot study tested this hypothesis. On 8 visits, healthy women (n = 8) received intravaginal taggant (2-butyl acetate, 2-pentyl acetate, isopropyl butyrate, or 2-pentyl butyrate; 30 mg) formulated in hydroxyethylcellulose or tenofovir placebo gel. A second group (n = 4) of women received the same formulations administered dermally on the forearm to determine if skin administration might confound the system. Breath samples were collected using bags before and after taggant administration for 1 hour. Samples were measured using a miniature gas chromatograph and/or gas chromatography-mass spectroscopy for ester taggant, alcohol, and ketone concentrations. After vaginal administration, 2-butyl acetate, 2-pentyl acetate, and metabolites were observed in breath, whereas isopropyl butyrate, 2-pentyl butyrate, and metabolites were not. Some women reported self-resolving, mild burning (24/64 visits) with vaginal administration or a "bubblegum" taste (7/64 visits). No taggants or metabolites were detected following dermal application. A "breath test" for adherence to antiretroviral vaginal gel application appears physiologically and technically feasible.

Biological Markers of Sexual Activity

“…32 Laboratory research also is needed to better characterize and improve the use of existing SBMs. For example, the Centers for Disease Control and Prevention is conducting preliminary testing on the detection of PSA in rectal swabs from men as a marker of semen exposure during unprotected receptive anal intercourse.…”

Attitudes and perceptions towards novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey

“…Given past studies that showed the chemical taggants used for the breath test approach in vaginal gel products caused an unfavorable taste for some women [14, 15], survey respondents were asked an additional question about women’s acceptance of the method if they knew it would result in an unfavorable taste. Over three-quarters (78.6%) of respondents said that it was very likely or somewhat likely that women would refuse the method if this was the case (data not shown).…”

Cell Phone-Based and Adherence Device Technologies for HIV Care and Treatment in Resource-Limited Settings: Recent Advances

“…Newer EAMs are in development, including ingestion monitors [59] and metabolite detectors [60]. The best-described ingestion monitor, Proteus, involves pills embedded or encapsulated with a microchip that, upon contact with digestive fluids, transmits a signal to a transponder (a disposable patch) worn by an individual.…”